In monocyte/macrophage‐derived osteoclasts, DPP‐4/CD26 expression is progressively upregulated under certain pathological conditions, such as osteolytic bone lesions from multiple myeloma, osteosarcoma, adenocarcinoma (Nishida et al. 2014). Here, DPP4 is linked to plasma cell myeloma.